CureVac N.V (CVAC) Social Stream



CureVac N.V (CVAC): $3.69

0.28 (-7.05%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add CVAC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#252 of 360

in industry

CUREVAC NV (CVAC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CVAC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 3 $65 $41 $53 $3.62 1364.09%
2022-01-05 4 $55 $41 $48 $3.62 1225.97%
2022-01-18 4 $55 $41 $49.333 $3.62 1262.79%
2022-04-11 4 $52 $20 $37.666 $3.62 940.5%
2022-05-09 3 $52 $17 $29.666 $3.62 719.5%
2022-05-27 3 $52 $17 $29.333 $3.62 710.3%
2022-08-13 3 $52 $15 $28.666 $3.62 691.88%
2022-08-19 3 $52 $15 $28.333 $3.62 682.68%
2022-09-17 3 $52 $13 $27.666 $3.62 664.25%
2022-11-17 3 $34.001 $13 $21.667 $3.62 498.54%
2022-11-18 3 $34.001 $10 $19 $3.62 424.86%
2023-01-06 3 $34.001 $9 $17.667 $3.62 388.04%
2023-04-25 3 $34.001 $10 $21.667 $3.62 498.54%
2023-05-31 3 $24 $10 $18.333 $3.62 406.44%
2023-08-17 4 $24 $10 $17 $3.62 369.61%
2023-11-15 4 $24 $8 $16.25 $3.62 348.9%
2023-12-19 5 $24 $6.4 $15.85 $3.62 337.85%

The Trend in the Analyst Price Target


Over the past 13 months, CVAC's average price target has gone down $1.82.

CVAC reports an average of 147.8% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 3 34.001 10.0 21.667 11.39 90.23%
2023-05-05 3 24.000 10.0 18.333 8.24 122.49%
2023-05-31 3 24.000 10.0 18.333 9.65 89.98%
2023-06-08 4 24.000 10.0 17.000 10.50 61.9%
2023-12-19 5 24.000 6.4 15.850 4.10 286.59%

CVAC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 40 months, CVAC's average broker recommendation rating improved by 0.25.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CVAC as an investment opportunity.

  • In terms of how CUREVAC NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1897.41% of that group.
  • In the context of all US stocks, CUREVAC NV's number of analysts covering the stock is higher than 195.79% of them.
  • CVAC has a lower variance in analysts' estimates than -1482.06% of stocks in the large market cap category.
  • In the context of stocks in the large market cap category, CUREVAC NV's average analyst price target is higher than 329.02% of them.

Stocks similar to CUREVAC NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MRVI, ABCL, and RVMD.

Is CVAC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!